Cassona Global Imaging Ltd, a lead distributor of advanced medical imaging technology in Ghana and across Africa, has launched a groundbreaking recruitment initiative aimed at bridging the healthcare ...

Rezpeg's promising Phase 2b data makes Nektar Therapeutics a strong contender in the AD market. Click here to read an ...

A significant boost in the 2025-2026 National Budget empowers Fiji’s health ministry to drastically enhance public health ...

The Canadian government has made changes to which educational programs can lead to a work permit upon graduation. On 25 June, ...

Women-centric probiotic products are gaining immense traction due to their specific applications in gut, vaginal, and ...

This roundtable brought together developers, contractors and architects involved in the delivery of health infrastructure in the region, alongside representatives from the North West’s NHS Trusts.

Nektar Therapeutics stock surged 116% in premarket trading after announcing successful Phase 2b trial results for its atopic dermatitis treatment.

Tailoring medicines to an individual’s genetic profile is now possible. One critical aspect is genetic testing that reduces ...

Regeneron remains committed to supporting patient access to medications and believes that patients should be able to access whatever therapy their physician prescribes for them. In the past decade, ...

Chugai Pharma presents positive data from NXTAGE phase I/II study of NXT007 in people with haemophilia A at ISTH 2025 Congress: Tokyo Tuesday, June 24, 2025, 13:00 Hrs [IST] Chuga ...

Nicole Verdun, MD, super office director of the FDA’s Office of Therapeutic Products (OTP) and her deputy Rachael Anatol, PhD ...